Log in to save to my catalogue

Proton-driven transformable nanovaccine for cancer immunotherapy

Proton-driven transformable nanovaccine for cancer immunotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7719078

Proton-driven transformable nanovaccine for cancer immunotherapy

About this item

Full title

Proton-driven transformable nanovaccine for cancer immunotherapy

Publisher

London: Nature Publishing Group UK

Journal title

Nature nanotechnology, 2020-12, Vol.15 (12), p.1053-1064

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Cancer vaccines hold great promise for improved cancer treatment. However, endosomal trapping and low immunogenicity of tumour antigens usually limit the efficiency of vaccination strategies. Here, we present a proton-driven nanotransformer-based vaccine, comprising a polymer–peptide conjugate-based nanotransformer and loaded antigenic peptide. The...

Alternative Titles

Full title

Proton-driven transformable nanovaccine for cancer immunotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7719078

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7719078

Other Identifiers

ISSN

1748-3387

E-ISSN

1748-3395

DOI

10.1038/s41565-020-00782-3

How to access this item